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erated a homozygous Nrf2 knockout human embryonic stem cell (hESC) line, H9Nrf2KO-A13, using the CRISPR/
Cas9 genome editing method. The Nrf2 homozygous knockout H9 cell line maintains pluripotency, differentia-
tion potential into three germ layers, and a normal karyotype.
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We generated a cell line (H9Nrf2KO-A13) that is a homozygous
knockout of Nrf2 by targeting exon 4 of Nrf2 using the CRISPR/Cas9
gene editing system (Fig. 1A). H9 cells were electroporated with preas-
sembled Cas9 protein/single-chain guide RNA (sgRNA) ribonucleopro-
teins (RNPs) targeting the transactivation domain of Nrf2 (Fig. 1B).
Four days after electroporation, cells were reseeded as single cells to ob-
tain single-cell-derived clones. To validate the Nrf2 knockout, we per-
formed targeted deep sequencing. Among 106 clones, we found three
homozygous mutant lines and a biallelic 14-nucleotide-deleted and 2-
nucleotide-inserted line, H9Nrf2KO-A13 (Fig. 1C); thesewere expanded
and stored for further characterization.
The H9Nrf2KO-A13 line was characterized both in terms of its mo-
lecular phenotype and differentiation potential. The H9Nrf2KO-A13
line is morphologically normal (Fig. 1D). ICC data revealed that the
H9Nrf2KO-A13 line is OCT4-, SSEA4-, TRA-1-60-, and TRA-1-80-positive
(Fig. 1E). We conﬁrmed that the CRISPR/Cas9 gene editing process did
not introduce any chromosomal abnormality by determining the cell
line's karyotype (Fig. 1F). To conﬁrm its differentiation potential, we
subcutaneously injected the clone into immunodeﬁcient mice to test
for teratoma formation that resulted in cell types representing the
three germ layers (Fig. 1G). Additionally, the mRNA expression levels
of markers representing the three germ layers were examined in 14-
day-cultured embryonic bodies (EBs) (Table 1). Finally, to conﬁrm the
safety of the cell line, we tested for mycoplasma (data not shown), vi-
ruses, and bacterial infections (Fig. S1).
In summary, the Nrf2 homozygous knockout hESC line described
herein is karyotypically normal and exhibits pluripotency. This line iser the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.A) Schematic diagram of the generation of Nrf2 homozygous knockout clones. B) Schematic of the Nrf2 gene and the Cas9/gRNA target site. C)Mutation information for the targeted
region of the H9Nrf2KO-A13 clone. Images represent cellmorphological (D), immunocytochemistry stainingwith the indicatedmarkers of pluripotency (E), and karyotype analysis (F). G)
H&E staining of a teratoma, indicating differentiation into the three germ layers (×40). Note the tissues from the endoderm (gut), mesoderm (osteoid), and ectoderm (neuronal
epithelium, pigmented cells). Table 1. The relative fold changes of gene expression between EB and ES.
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pathway in development.
2. Materials and methods
2.1. Cell culture
The human embryonic stem cell H9 line was obtained from Wicell
(WA91; NIH Registration Number 0062). Cells were grown in Essential
8Medium (Gibco) on laminin 521 (Corning)-coated plates (Thomson et
al., 1998). Cells were passaged using ReLeSR (Stem Cell Technologies).
2.2. Guide RNA
RNA was in vitro-transcribed using the MEGAshortscript T7 Kit
(Ambion) according to the manufacturer's manual. sgRNA template
was generated by the annealing and extension of two complementary
oligonuceotides (Table S1). Transcribed RNA was puriﬁed using the
MEGAclear Transcription Clean-Up Kit (Ambion). Puriﬁed RNA was
quantiﬁed spectrophotometrically.2.3. Electroporation and targeted deep sequencing
Human ESCs were dissociated into single cells using ReLeSR. Cells
were resuspended in Nucleofection solution and electroporated with
30 μg Cas9 and 40 μg of in vitro-transcribed sgRNA using the Amaxa
P3 Primary Cell 4D–Nucleofector Kit (Lonza) (S. Kim et al., 2014).
After 4 days, cells were replated as single cells at a very low density
on laminin 521-coated plates in Essential 8 Medium supplemented
with a Rho kinase (ROCK) inhibitor (Stemgent). Individual colonies
were picked and expanded. Genomic DNA was then extracted using
QuickExtract (Epicentre). The target regionwas ampliﬁed and subjected
to paired-end read sequencing using Illumina MiSeq at LAS (Table S2).2.4. EB formation
hESCs on vitronectin (Gibco)-coated plates were detached using a
cell scraper. Cellswere gently spin-downed and re-suspended in EBme-
dium comprised of DMEM/F12 (Gibco), 20% knockout serum replace-
ment (Gibco), 1% nonessential amino acids (Gibco), and 0.1 mM β-
mercaptoethanol (Invitrogen) for 14 days.
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The cells (106) were injected into NOD Scid Gamma (NOD.Cg-Prkdc-
scid Il2rgtm1Wjl/SzJ)mice (The Jackson Laboratory). The formed teratomas
were ﬁxed in formaldehyde, parafﬁn-embedded, and sectioned. To ana-
lyze the three germ layers, the sectioned slides were histologically ex-
amined by hematoxylin and eosin (H&E) staining.
2.6. Real-time quantitative PCR (qRT-PCR) analysis
Total RNA was extracted from cells using the RNeasy Mini Kit
(QIAGEN) according to themanufacturer's instructions. cDNA synthesis
was performed using the RNA-to-cDNA EcoDry Premix (Clontech). qRT-
PCR assays were performed in triplicate using TaqMan™ Master Mix
(ABI) (J.H. Kim et al., 2014).
2.7. Immunostaining
Cells were ﬁxed and permeabilized. The ﬁxed sampleswere incubat-
ed for 24 h at 4 °C with anti-Oct4 (Santa Cruz), anti-SSEA-4 (Millipore),
TRA-1-60 (Millipore), or TRA-1-81 (Millipore) antibodies. The samples
were then washed and incubated in ﬂuorescein-conjugated secondary
antibodies with DAPI (Thermo). Slides were photographed using an
Olympus DP72 camera and imaged with CellSens software.
2.8. Karyotyping
The G-banding karyotype analysis was performed on 20 single
clones at a band resolution of 500.Conﬂict of interest
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